Sale Date Ended
Course "Complaint Handling and Management: From Receipt to Trending" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analyzed, and corrective action shall be taken. The results of this evaluation should lead to a conclusion regarding whether the complaint was valid, what the root cause of the complaint was, and what action is necessary to prevent further occurrences. Complaints cannot be ignored. They are an excellent indicator of problems with the use, design, and/or manufacture of a product. A single complaint that is thoroughly investigated may lead a company to take remedial or corrective action. It may also take an ongoing analysis of numerous complaints before a trend is spotted that causes a company to initiate changes in their product, labeling, packaging or distribution. The regulatory expectations for both pharmaceuticals and medical devices will be emphasized as well as overview of best practices for timely and effective investigations. Trending is the only way a company can stay on top of emerging quality issues and address those that are most pressing.
Medical Device Reporting (MDR) is the mechanism for FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. User Facilities (e.g., hospitals, nursing homes) are required to report suspected medical device related deaths to both the FDA and the manufacturers. User facilities report medical device related serious injuries only to the manufacturer. If the medical device manufacturer is unknown, the serious injury is reported by the facility to FDA. Health professionals within a user-facility should familiarize themselves with their institution procedures for reporting adverse events to the FDA.
The MDR process impacts device user facilities, manufacturers, importers, and distributors. If you are a device user facility, you must report deaths and serious injuries that a device has or may have caused or contributed to, establish and maintain adverse event files, and submit summary annual reports. If you are a manufacturer or importer, you must report deaths and serious injuries that your device has or may have caused or contributed to, you must report certain device malfunctions, and you must establish and maintain adverse event files. If you are a manufacturer, you must also submit specified follow-up.
Recall means the correction or removal of a device for human use where FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death. It is an action taken to address a problem with a medical device that violates FDA law. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.
A medical device recall does not always mean that you must stop using the product or return it to the company. A recall sometimes means that the medical device needs to be checked, adjusted, or fixed. If an implanted device (for example, a pacemaker or an artificial hip) is recalled, it does not always have to be removed. When an implanted device has the potential to fail unexpectedly, companies often tell doctors to contact their patients to discuss the risk of removing the device compared to the risk of leaving it in place. FDA classifies medical device recalls into three categories, representing the potential risk to public health: Class I, II, and III.
Why should you attend:
Areas Covered in the Session:
Areas of special concentration will include:
Who will benefit:
Day 1 Schedule
Medical Device Reporting
Exercise and Recap of Day 1
Day 2 Schedule
Medical Device Reporting
Exercise and Recap of Day 2
Regulatory Affairs & Compliance Consultant,
David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space.
Location: Cape Town, SA Date: July 25th and 26th, 2016 and Time: 9:00 AM to 6:00 PM
Venue: WILL BE ANNOUNCED SOON
Register now and save $200. (Early Bird)
Price: $1,695.00 (Seminar Fee for One Delegate – Without stay)
Until June 20, Early Bird Price: $1,695.00 from June 21 to July 23, Regular Price: $1,895.00
Price: $2,095.00 (Seminar Fee for One Delegate – With stay)
Until June 20, Early Bird Price: $2,095.00 from June 21 to July 23, Regular Price: $2,295.00
Register for 5 attendees (With stay) Includes Price: $7,333.00 You Save: $3,142.5 (30%)*
Until June 20, Early Bird Price: $1, 0475.00 from June 21 to July 23, Regular Price: $1, 0675.00
NetZealous DBA as GlobalCompliancePanel
Registration Link - http://bit.ly/1TX9GKm-complaint-handling
Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel